CRSP Stock-Based Compensation
Crispr Therapeutics Ag · Stock-Based Compensation
CRSP Stock-Based Compensation
Latest reported$68.32Mperiod ending
CRSP TTM Stock-Based Comp ($3.68M → $68.32M)
TTM stock-based compensation
High-resolution chart · PNG
CRSP stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 68,320,000 | |
| 68,611,000 | |
| 72,499,000 | |
| 76,370,000 | |
| 81,309,000 | |
| 87,374,000 | |
| 86,567,000 | |
| 83,040,000 | |
| 81,465,000 | |
| 79,558,000 | |
| 81,028,000 | |
| 85,413,000 | |
| 89,990,000 | |
| 93,077,000 | |
| 97,947,000 | |
| 100,910,000 | |
| 102,564,000 | |
| 106,043,000 | |
| 102,390,000 | |
| 95,552,000 | |
| 86,593,000 | |
| 73,959,000 | |
| 66,018,000 | |
| 58,945,000 | |
| 53,048,000 | |
| 48,537,000 | |
| 44,057,000 | |
| 45,225,000 | |
| 41,936,000 | |
| 39,074,000 | |
| 34,985,000 | |
| 28,939,000 | |
| 25,753,000 | |
| 20,709,000 | |
| 18,873,000 | |
| 15,922,000 | |
| 13,347,000 | |
| 13,568,000 | |
| 10,844,000 | |
| 7,992,000 | |
| 6,728,000 | |
| 3,358,000 | |
| 3,684,000 |